Consumer Products
Food
Manufacturing

Natural Alternatives International

$10.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-1.77%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NAII and other stocks, options, ETFs, and crypto commission-free!

About

Natural Alternatives International, Inc. Common Stock, also called Natural Alternatives International, is a formulator, manufacturer and marketer of nutritional supplements. Read More It operates through the following segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The Private Label Contract Manufacturing segment provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. The Patent and Trademark Licensing segment primarily includes royalty income from its license and supply agreements associated with the sale and use of beta-alanine under its name CarnoSyn and SR CarnoSyn trade names. The company was founded by Mark A. LeDoux in 1980 and is headquartered in Carlsbad, CA.

Employees
246
Headquarters
Carlsbad, California
Founded
1980
Market Cap
82.55M
Price-Earnings Ratio
7.70
Dividend Yield
0.00
Average Volume
10.45K
High Today
$10.96
Low Today
$10.70
Open Price
$10.96
Volume
7.29K
52 Week High
$11.88
52 Week Low
$8.73

Collections

Consumer Products
Food
Manufacturing
Nutritional Supplements
Healthcare
Retail
Health And Wellness
Health

News

PR NewswireMar 19

Natural Alternatives International, Inc. Prevails in Much-Anticipated Federal Circuit Appeal on CarnoSyn® Beta-Alanine Patents

CARLSBAD, Calif., March 19, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ: NAII), a leading formulator, and marketer of customized nutritional supplements announced today that the U.S. Court of Appeals for the Federal Circuit has ruled in NAI's favor, holding that its CarnoSyn® beta-alanine patents are "patent eligible" under existing law. The Court's decision reverses a 2017 ruling by a California district court and revives important patent rights in NAI's existing patent po...

7
MarketBeatMar 7

Stock Price, News, & Analysis for Natural Alternatives International

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering...

3
Simply Wall StFeb 20

Why We’re Not Keen On Natural Alternatives International, Inc.’s (NASDAQ:NAII) 17% Return On Capital

Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Today we’ll evaluate Natural Alternatives International, Inc. (NASDAQ:NAII) to determine whether it could have potential as an investment idea. In particular, we’ll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business. First of all, we’ll work out how to calculate ROCE. Next, we’ll compare it to oth...

0

Earnings

$0.00
$0.13
$0.25
$0.38
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected May 13, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.